Increases lower limit of quantification when substituted for ELISA kit standard & sample diluents.
As an antibody concentration standard and as sample diluent, ProStabix prevents aggregation
✅ Extended lower detection range
✅ Reduced non-specific binding
✅ Consistent performance across plates
✅ Compatible with existing protocols
See the performance difference side-by-side
| Parameter | Traditional PBS | Our Advanced Buffer |
|---|---|---|
|
Protein Stability |
Poor |
Excellent |
|
Signal Enhancement |
1x |
3.2x |
|
Aggregation Prevention |
Limited |
Superior |
|
Storage Stability |
7 Days |
+6 months |
In Vivo and In Vitro ApplicationsIntegrate seamlessly into experimental drug delivery and analytical recovery methods
Our reagent solution enable enhanced sensitivity across multiple analytical platforms, supporting your most demanding assay requirements.
Stabilizes antibodies across a wide pH range and prevents aggregation. Disaggregates high-concentration antibodies when diluted to therapeutic dosages. Enhances shelf life and improve sample freeze–thaw stability.
Maintains normal osmolarity and pH to prevent aggregation, increasing extraction yields from tissues. Replaces balanced salt solutions to boost monomer recovery by up to 50%.
Optimized for topical ocular, nasal, and inhaled delivery. Prevents aggregation during tissue permeation and stabilizes antibodies during vibrating-mesh nebulization.
Serves as both antibody concentration standard and sample diluent. Prevents aggregation and increases the lower limit of quantification when replacing standard ELISA kit diluents.
Execute with improved signal clarity
Confirm reproducibility and accuracy
Improved resolution and reliability in low-analyte detection
Monomer Recovery
Aggregate Formation
Peak Resolution
Reproducibility
Our published research and insights that advance knowledge and inform practice. Through rigorous analysis and collaborative expertise, we deliver high-quality publications that contribute to ongoing conversations in our field.
Steven A. Giannos, Edward R. Kraft, Zhen-Yang Zhao, Kevin H. Merkley & Jiyang Cai
Steven A. Giannos, Edward R. Kraft, Zhen-Yang Zhao, Kevin H. Merkley & Jiyang Cai
Text placeholder here: Boost sensitivity and reliability in low-analyte detection
✅ Reduced VEGF aggregation and precipitation
✅ Improved isoform differentiation
✅ Enhanced binding kinetics analysis
✅ Stable signal over extended timeframes
Perfect for pharmaceutical research focusing on angiogenesis, tumor biology, and therapeutic development.
We offer free or discounted samples for academic and biotech partners.
